The Organ Procurement and Transplantation Network (OPTN) offers policy proposals for public comment from January 22 through March 23, 2018.
Comments and replies will be published on the OPTN public comment page, to promote transparency and trust in the national transplant system. Visitors can also share comments on social media, if they wish.
Feedback for selected proposals will be sought via a response form. This is part of a trial to study potential enhancements to the public comment process. For the proposals using the response form, the comments related to the proposal will be displayed on the public comment page in the same manner as the blog-style responses to all other proposals.
One of the proposals is a draft of an updated OPTN/UNOS strategic plan. The plan, to be finalized by the OPTN/UNOS Board of Directors after public input, will serve as a roadmap to help prioritize the OPTN’s work through 2021 and provide metrics to assess progress toward key goals.
We encourage patients, transplant candidates and recipients, living donors, donor families and transplant professionals to learn more about the proposals below and provide valuable feedback to help shape U.S. organ transplant policy:
- Aligning VCA program membership requirements with other transplant programs
- Modifications to the distribution of deceased donor lungs
- Clarifying informed consent policies for transmissible disease risk
- Concept paper on expedited organ placement
- Reducing reporting burdens and clarify policies on extra vessels
- Guidance on optimizing VCA recovery from deceased donors
- Changes to waiting time criteria for kidney pancreas candidates
- Modifying the lung Transplant Recipient Form to improve post-transplant lung function data
- Revising OPTN Bylaws Appendix L
- White paper on manipulating waitlist priority
- Guidance for ABO subtyping of Blood Type A and AB organ donors
- Concept paper on improving the OPTN/UNOS committee structure
- Guidance on deceased donor requested information
- OPTN/UNOS strategic plan
- Review board guidance on heart candidates with exceptions for HCM and RCM
